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Abstract
The polyomavirus hr-t class of mutants has served as a major prototype to study the function of middle T  small T in the virus lytic
cycle (T.L. Benjamin, 1982, Biochem. Biophys. Acta 695 (2), 69–95). The properties of these middle T  small T defective mutants were
defined by comparisons with “wild-type” strains reconstructed by marker rescue. Similar comparisons in the A2 genetic background have
revealed a number of differences (L. Chen and M. Fluck, 2001b, J. Virol. 75, 8380–8389). Here we describe a major divergence in their
effects on cell-cycle progression of both permissive mouse NIH3T3 cells and semipermissive Fischer rat FR3T3 cells. Infection of NIH3T3
or FR3T3 cells in serum-rich medium with wild-type A2 (WTA2) or WTA2-derived middle T  small T-defective mutants did not perturb
cell cycling, tested up to entry into the third cycle. In contrast, infection with four hr-t mutants analyzed, examined in detail with mutant
B2, resulted in an accumulation of cells in G2/M in a dose-dependent and serum-independent manner. The arrest began in the first cell cycle.
At multiplicities of infection above 10 PFU/cell, 50–80% of the cell population became arrested by the end of the second cycle. FR3T3
arrested cells detached from the monolayer with a rounded up morphology. Three other hr-t mutants investigated were also found to arrest
cells in G2/M. Expression of middle T and/or small T either in trans or in cis did not abrogate this cell-cycle arrest, as demonstrated in the
latter case with the middle T  small T expressing strain “wtB2” obtained by repair of the B2 deletion. In FR3T3 cells, the induction of
a cell-cycle arrest by wtB2 was accompanied by a severe delay and reduction in neoplastic transformation relative to WTA2 used at equal
dose. Mutation(s) in the C-terminal domain of large T antigen, upstream of the site-specific DNA binding activity, is necessary for the
cell-cycle block. The possible causes for the cell-cycle block are discussed.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Hr-t mutants were originally isolated in an attempt to
genetically identify the viral transforming function(s). The
assumption made was that this function would also be
important for virus growth (Benjamin 1970, 1982). A dual
selection was applied for loss of viability in normal 3T3
cells, and complementation of this defect in polyoma-trans-
formed 3T3 cells. Most hr-t mutants evolved with deletions
in the large T intron (Feunteun et al., 1976; Hattori et al.,
1979), which do not affect the large T protein but eliminate
or alter middle T and small T proteins (Schaffhausen et al.,
1978). While all the mutants isolated were found com-
pletely defective in their ability to transform cells (Ben-
jamin 1970; Fluck et al., 1977), their growth properties
turned out to depend largely on the host cell. Primary cells
and some established cell lines were capable of supporting
virus growth while others were not; the same was true for
transformed cells (Goldman and Benjamin, 1975). In cells
that are nonpermissive for hr-t mutants, modest decreases in
the accumulation of viral genomes and viral capsid proteins
were observed, but these decreases were deemed not large
enough to explain the defect in production of infectious
progeny (Garcea and Benjamin, 1983). The major defect
was found to take place during the encapsidation of the viral
minichromosomes (Garcea and Benjamin, 1983) and was
correlated with the absence of phosphorylation of serine and
threonine (especially T63 and T156) in the major capsid
protein VP1 (Garcea et al., 1985; Li and Garcea, 1994).
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While investigating the effect of polyomavirus infection
on the kinetics of cell-cycle progression in NIH3T3 cells,
we discovered that in contrast to infection with WTA2 and
A2-derived-mutants infection with the hr-t mutant B2 in-
duces a G2/M cell-cycle arrest. Here we report on the
characterization of this arrest in both mouse NIH3T3 and rat
FR3T3 cells. We also demonstrate that induction of a G2/M
cell-cycle arrest is a characteristic shared by three other hr-t
mutants tested.
Results
The cell cycle of NIH3T3 cells infected with WTA2 is
unperturbed while infection with the hr-t mutant B2
results in an accumulation of cells with 2C DNA content
The effect of polyomavirus infection on the cell-cycle
progression in NIH3T3 cells was analyzed over a 48-h time
period. Cells were synchronized by induction of a quiescent
state following serum starvation, infected at a multiplicity
of infection (m.o.i.) of 10 plaque-forming units (PFU) cell,
released from G0 with medium supplemented with 10%
serum, as described in protocol 2 under Materials and Meth-
ods, and analyzed by FACS. In mock-infected cells (Fig.
1A), approximately 50% of the cells had entered into S
phase at 20 h postrelease (hpr). The first round of cellular
DNA synthesis was completed by 24 hpr. At that time, 37%
of the population was in G2/M and 50% of the population
had progressed to G1 of the second cycle. At 30 hpr, 42%
of cells were in S phase of the second cell cycle, and by 48
hpr the majority of the population, 70%, had accumulated in
the third G1. The high percentage of G1 cells at 48 hpr
represents a confluency-induced arrest in G0/G1. In exper-
iments carried out at a lower density, the cell-cycle profile
at 48 h resembled that of an asynchronous population (data
not shown).
Infection with WTA2 (Fig. 1B) or the A2-derived middle
T  small T defective A185 deletion mutant (Fig. 1C) did
not alter the passage of cells through the cell cycle(s).
Similarly to the mock-infected control, the WTA2- and
A185-infected populations moved through two full cycles
before undergoing a confluency-induced G0/G1 arrest by 48
hpr. In the case of B2 (Fig. 1D), the cell population entered
Fig. 1. Cell-cycle profiles of mock-, WTA2-, mutant A185-, and mutant B2-infected NIH3T3 cells. NIH3T3 cells were synchronized in G0 by protocol 2
and infected at an m.o.i. of 10 PFU/cell. Progression through the cell-cycle phases was followed for 48 h. Cells were fixed and stained, and 5000 cells for
each sample were analyzed for DNA content by flow cytometry. FACS profiles of samples taken at 12, 20, 24, 30, and 48 hpr for mock- (A), WTA2- (B),
A185- (C), and B2-infected cells (D) are shown. In this experiment “hours post release” (hpr) is equivalent to “hours post infection.” In D, the y-axis scale
is enlarged 1.5-fold.
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S phase with the same kinetics as uninfected or WTA2-
infected cells. However, cells began accumulating in G2/M
phase from the first cell cycle; the fraction of G2/M cells
was 60% at 24 hpr, 47% at 30 hpr, and greater than 50% at
48 hpr. In all other populations the fraction of cells in G2/M
was approximately 40, 20, and 15% at similar times, re-
spectively. In these experiments, cytopathic effects (CPE)
were visible by 72 hpr. Similar results were obtained in
numerous experiments (as seen below).
Some variations in cell-cycling kinetics were seen from
experiment to experiment. For example, in the experiment
shown in Fig. 1, approximately 50% of the population had
progressed to G1 at 24 hpr. In contrast, in the experiment in
Table 1, a return of 50% of the population to G1 was
achieved by 27 hpr, demonstrating a 3-h lag in cell-cycle
progression between these two experiments. The percentage
of cells accumulating with 2C DNA content among B2-
infected cells also varied between experiments. In the ex-
periments shown, the percentage of arrested cells at 48 hpr
with a multiplicity of infection of 10 varied between 50%
(Fig. 1) and 72% (Table 4).
A correlation was seen between the magnitude of the
B2-induced cell-cycle arrest and the state of quiescence of
the cells at the time of infection. This state was affected in
two opposite ways by variable factors in different serum
batches. On occasion, the release into the cell cycle was
poor; the proportion of cells remaining in G0/G1 was high
at all times and the fraction of cells of accumulating in G2
was smaller. Alternatively, a poor G0 arrest before infection
resulted in decreased infection efficiency (and hence m.o.i.),
as the peak of susceptibility for infection occurs in G0 or
early G1 (Chen and Fluck, 1993), and therefore a lowered
fraction of G2-arrested cells was observed. In some cases
quiescence was not achieved using protocol 2 and the more
stringent protocol 1, involving both confluency and serum
starvation, was then employed. Otherwise, similar results
were obtained with both protocols 1 and 2.
Because of the variation seen with different serum
batches, experiments were also carried out in serum-poor
medium. Quiescent cells, obtained using protocol 2, were
infected and refed with serum-poor medium. The cell-cycle
profiles are given in Table 1, with the results for cultivation
in serum-rich (10%) medium for comparison. In low serum
conditions, at least 60% of WTA2-infected cells entered the
first S phase and most arrested in the second G1 phase,
while 90% of WTA2-infected cells refed with serum-rich
medium entered the first S phase, and most progressed
through two complete cell cycles. In low serum, at least
65% of the B2-infected population entered the first S phase,
as seen at 18 hpr. Forty-eight percent of the population was
already arrested in G2 by 30 hpr. The apparent decrease to
about 30% at 48 hpr is likely to reflect the loss of arrested
cells in the supernatant (see below), as well as the lack of
progression through a second cell cycle. The mock- and
WTA2-infected populations had between 16 and 21% 2C
DNA content at 48 hpr. These results demonstrate that the
cell-cycle arrest induced by B2 is not entirely dependent
upon the presence of serum.
Analysis of viral DNA replication and gene expression in
WTA2-, A185-, and B2-infected NIH3T3 cells
Genome amplification was examined by Southern blot
analysis and quantitated by phosphorImager. The level of
input genomes (Fig. 2A) harvested at 4 h postinfection (8
hpr) demonstrates that equivalent doses of virus were used
in the infection with the three viral strains. Comparisons of
genome levels at 8 and 48 hpr showed high amplification,
approximately 150-fold, for both WTA2 and B2. Amplifi-
cation of the A185 mutant, on the other hand, was only
10-fold by 48 h. The defect in expression (see below) and
replication of the A185 mutant have been reported and
discussed elsewhere (Chen and Fluck, 2001b; Chen et al.,
1995).
Table 1
Effect of serum factors on the B2-induced G2/M cell-cycle arresta
Timeb Mock-10%c WTA2-10%c WTA2-0.5%c B2-10%c B2-0.5%
%G1 %S %G2 %G1 %S %G2 %G1 %S %G2 %G1 %S %G2 %G1 %S %G2c
0 94 1 5
12 89 2 9 96 2 3 85 2 13 94 2 4
18 80 13 7 79 15 6 43 57 0 80 11 9 36 65 0
21 4 97 0 16 82 2 34 32 34 0 100 0 19 24 57
24 9 36 55 9 22 69 46 12 43 4 21 75 20 18 63
27 44 15 42 39 6 55 59 10 31 21 11 68 35 13 52
30 65 11 24 63 11 26 76 6 18 38 9 53 41 11 48
36 57 44 0 37 59 5 74 15 11 19 32 49 43 9 48
48 68 12 21 60 23 17 71 13 16 24 19 57 52 17 32
a NIH3T3 cells were synchronized and released from G0 according to protocol 2. Infections were carried out at a multiplicity of 10 PFU/cell. The cells
were refed with serum-rich medium (10% serum) or serum-poor medium (0.5% serum) as indicated.
b Sample harvest time: hours postrelease from G0, equivalent to hours postinfection.
c FACS analysis was carried out on 5000 cells for each sample. The percentage of cells in the G1, S, or G2/M phases were calculated as described under
Materials and Methods.
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Viral proteins expressed in NIH3T3 cells infected with
WTA2, A185, and B2 are shown in Fig. 2B. The detection
of a cellular protein by the antitumor serum shows that
equivalent amounts of proteins were loaded. As expected,
all three early proteins, large T, middle T, and small T, were
expressed by WTA2, while only large T was expressed by
the A185 and B2 mutants (see Materials and Methods).
However, in B2-infected cells, the large T protein was
expressed with faster kinetics and in higher amounts than in
cells infected with either the A185 mutant or the WTA2.
Serial dilution analysis of the 48-hpr samples revealed that
B2 produced approximately eight-fold more large T protein
than WTA2 (Fig. 2C). This trend was observed repeatedly.
The additional proteins observed in B2-infected cells also
have also been detected in WTA2- or A185-infected cells at
higher multiplicities or at later times in infections. These
proteins are likely to be cellular, as they are not seen with a
monoclonal antibody directed to the N-terminus common to
large, middle, and small T (data not shown); furthermore, they
do not correspond to viral proteins of predicted size. The
synthesis of the late VP1 protein also demonstrated faster
kinetics and marked overexpression in B2-infected cells. In
this case, VP1 was expressed at approximately 32-fold higher
levels in B2- compared to WTA2-infected cells (Fig. 2C).
The cell-cycle arrest is multiplicity dependent
To investigate the dose dependence of the cell-cycle
arrest induced by B2, infections were carried out at different
multiplicities of infections and followed for 48 h, according
to protocol 2. The cell-cycle profiles at various times postin-
fection are given in Table 2. The mock-infected population
progressed through two cell cycles and 60% was detected in
G0/G1 at 48 hpr. At a multiplicity of 1, no significant
accumulation in G2/M was seen. At a multiplicity of 3, 34%
of the population was arrested in G2/M at 48 hpr compared
to 17% in the mock-infected control. The accumulation of
cells with 2C content at 48 hpr increased with the multi-
plicity of infection and leveled off at an m.o.i.  10 with
approximately 60–70% of the population arrested with 2C
DNA content. Furthermore, at the higher multiplicities (also
10), arrested cells were detected at the end of the first cell
cycle. For example, at an m.o.i. of 20, 37% of the popula-
tion was in G2/M at 30 hpr, versus 11% in the mock-
infected control. The effect of increasing the WTA2 m.o.i.
was compared to that seen with B2 (Table 3). Infection with
WTA2 up to a multiplicity of 30 PFU/cell resulted in the
accumulation of 25–35% of the population in G2/M at 48
hpr. In contrast, the percentage of cells in G2/M following
infection with B2 was significantly greater at all multiplic-
ities (between 55 and 72%). Analysis of viral proteins (data
not shown) showed that, at equivalent m.o.i.s, higher levels
of large T, VP1, and viral genomes were consistently pro-
duced in B2- compared to WTA2-infections.
When in a separate experiment the multiplicity was in-
creased to 50 PFU/cell, a cell-cycle arrest was induced in
40% of the WTA2-infected population, compared to 20% in
mock- and 80% in B2-infected cells (data not shown).
Analysis of viral proteins showed higher protein levels in
cells infected with B2 at an m.o.i. of 10 PFU/cell (of which
56% arrested in G2/M) than in cells infected with WTA2 at
an m.o.i. of 50 PFU/cell.
Expression of middle T and/or small T does not abrogate
the cell-cycle arrest induced by the B2 mutant
To test whether the presence of middle T and/or small T
could relieve the G2/M cell-cycle arrest induced in infec-
Fig. 2. Comparison of the accumulation of viral genomes and early and late
viral proteins in WTA2-, mutant A185-, and mutant B2-infected NIH3T3
cells. NIH3T3 cells were infected at an m.o.i. of 10 PFU/cell according to
protocol 1 (infection at 4 h postrelease of cells from G0). Total DNA (A)
was isolated at 8 and 48 hpr, digested with EcoRI, and blotted to nitrocel-
lulose membranes. Membranes were hybridized with WTA2 genomic
DNA and exposed to X-ray film. Protein lysates (B) were collected at the
times indicated (hpr) and one-fifth of the sample was assayed serially for
early proteins with an antitumor antibody and, after stripping, with anti-
VP1 as described under Materials and Methods. The position of the early
proteins (large T, middle T, and small T) is shown. The antitumor serum
recognizes a cellular protein. (C) Protein lysates harvested at 48 hpr were
serially diluted and assayed first for early and, after stripping, for late
proteins. The dilution factor is indicated.
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tions with B2, three types of experiments were carried out.
First, NIH3T3 cells stably expressing small T, middle T, or
middle T small T were infected with B2 using protocol 1,
and the accumulation of G2/M cells at 48 h was compared
to those obtained with NIH3T3. In NIH3T3 cells, 74% of
the population was arrested in G2/M by 48 hpr. Small
T-expressing cells were similarly arrested with 76% of the
population accumulated in G2/M by 48 hpr. In middle
T-expressing cell lines (middle T alone, or middle T 
small T), the fraction of cells arrested in G2/M by 48 hpr
was reduced to 42%. However, the difficulty of arresting
these transformed cells in G0 resulted in a less efficient
infection, as demonstrated by the comparative analysis of
input viral DNA (data not shown). Since the percentage of
cells accumulating with 2C content is strongly dependent on
the multiplicity, the decrease in viral input is likely to make
an important contribution to the lower percentage of cells in
G2/M cells observed at 48 h.
As a second strategy to express middle T and small T in
trans, mixed infections with WTA2 and B2 were carried
out. As seen by FACS analysis (Fig. 3), an accumulation of
cells with G2/M DNA content of similar magnitude to that
seen with B2 alone was observed in WTA2B2 mixed
infections. The analysis of early proteins (Fig. 4) showed
that in coinfection with B2, the expression of middle T and
small T from the WTA2 genome was markedly reduced.
Thus, the mixed infection strategy did not lend itself to a test
of the effect of middle T/small T.
As a third approach, expression of middle T and small T
was restored in B2 by exchange of a 679-bp fragment
encompassing the B2 deletion, as described under Materials
and Methods. As seen in Fig. 4, the wtB2 virus expressed
viral proteins at the same high level as B2. FACS analysis
showed that the wtB2 strain induced a similar accumulation
of cells with G2/M DNA content as that seen with B2 (Fig.
3). From these data, we conclude that middle T and small T
expression have little, if any, effect in overcoming the
cell-cycle arrest induced in B2-infected cells.
The induction of a G2/M cell-cycle arrest is a common
feature of hr-t mutants
To test whether the induction of a cell-cycle arrest is a
property unique to the B2 mutant or a common feature
Table 2
Effect of the multiplicity of infection on the accumulation of cells in G2/M in populations of B2-infected NIH3T3 cellsa
Timeb Mockc m.o.i. 1c m.o.i. 3c m.o.i. 5c m.o.i. 10c m.o.i. 20c m.o.i. 30c
G1 S G2 G1 S G2 G1 S G2 G1 S G2 G1 S G2 G1 S G2 G1 S G2
0 89 4 7
12 65 24 11 86 4 10 88 5 7 88 5 8 86 6 9 83 6 10 88 6 6
20 6 45 49 6 37 58 6 39 55 7 36 58 4 36 60 2 46 52 4 39 58
24 61 8 31 64 5 31 57 6 37 57 6 37 47 9 45 39 7 54 36 9 55
30 61 28 11 55 32 13 53 33 14 48 34 18 48 30 23 33 30 37 39 33 29
36 53 17 30 49 19 33 41 19 40 35 21 44 23 23 54 17 18 65 20 17 63
48 60 24 17 51 28 21 31 35 34 22 33 45 13 25 61 9 21 70 11 29 60
a NIH3T3 cells were synchronized and released from G0 according to protocol 2. Infections were carried out with different multiplicities of infection
(m.o.i.) as indicated. Percentage of cell population in G1, S, or G2/M is shown.
b Sample harvest time: hours postrelease from G0, equivalent to hours postinfection.
c FACS analysis was carried out on 5000 cells for each sample; the percentage of cells in the G1, S, or G2/M phases were calculated as described under
Materials and Methods.
Table 3
Effect of the multiplicity of infection on the accumulation of cells in G2/M in WTA2- and B2-infected NIH3T3 cellsa
Timeb WTA2c Timeb B2c
5 10 20 30 5 10 20 30
20 41 41 44 41 20 31 38 23d 45
24 42 30 42 32 24 50 47 60 49
30 16 14 15 13 30 33 44 52 47
36 32 28 29 35 36 43 46 35 70
48 23 28 35 26 48 55 56 71d 72
a NIH3T3 cells were synchronized and released from G0 according to protocol 2. Infections were carried out with different multiplicities of infection
(m.o.i.) as indicated.
b Sample harvest time: hours postinfection, equivalent to hours postrelease from G0.
c FACS analysis was carried out on 5000 cells for each sample; the percentage of cells in G1, S, and G2/M was calculated. Only the percentage of cells
in G2/M is shown here.
d Values represent an estimate as the percentages based on the calculated model did not accurately represent the raw data.
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among hr-t mutants, three other mutants were tested for
their ability to induce a G2/M cell-cycle arrest. These in-
clude two deletion mutants, NG18 and NG23, and the in-
sertion/point mutant NG59. Two rescued “wild-type”
strains were also tested: 18R4, the wild-type rescued in
NG18 background, and 59RA rescued from NG59. NIH3T3
cells were treated according to protocol 1. The progression
of the cell cycle was monitored by FACS and the percent-
ages of cells with G2/M DNA content at 48 h postrelease
are shown in Table 4. In all cases, infection with hr-t
mutants or the wild-types derived from them resulted in an
accumulation of cells with G2/M DNA content. Further-
more, these hr-t-derived strains overexpressed viral proteins
in relation to WTA2-infected cells, with slight differences
likely due to variations in input virus dose (data not shown).
We conclude that the four hr-t mutants tested induce a
G2/M cell-cycle arrest that is not abrogated by the expres-
sion of middle T and/or small T in three cases tested.
DNA synthesis inhibitors do not relieve the cell-cycle arrest
We have determined that, once initiated, viral DNA
synthesis is not restricted to the S phase, whether or not
middle T is expressed (L. Chen and M.M. Fluck, unpub-
lished data). To investigate the contribution of out-of-S-
phase viral DNA synthesis to the cell-cycle arrest, DNA
synthesis inhibitors were used to terminate viral DNA rep-
lication following the arrest in G2/M. NIH3T3 cells were
infected with WTA2 or B2 using protocol 2. DNA synthesis
inhibitors, aphidicolin (Huberman, 1981) and mimosine
(Gilbert et al., 1995), were added at one experimental point
(24 hpr) and two control points (12 and 30 hpr). Addition of
inhibitors at 12 hpr completely inhibited entry into S phase
and any amplification of viral genomes, as expected (data
not shown). Addition of inhibitors at 30 hpr arrested unin-
fected and WTA2-infected cells in early S phase of the
second cell cycle (data not shown). Addition of either
aphidicolin or mimosine at 24 hpr caused a rapid cessation
of viral (and presumably host) DNA replication in WTA2-
and B2-infected cells (data not shown). As shown in Table
5, the addition of the inhibitors at 24 h did not inhibit the
progression of WTA2-infected cells to the G1 phase of the
second cell cycle. In this case, 56% of the population had
already moved into the G1 phase of the second cell cycle at
the time of the addition of the inhibitor, while 34% of the
population was still in G2. Most (80%) of this G2 popula-
tion progressed to G1 after the addition of the inhibitor.
Furthermore, the majority of the total population (80–90%)
was unable to enter the second S phase and remained at the
G1/S border for the duration of the experiment. In the
B2-infected population, 58% was in G2/M at the time of
inhibitor addition (compared to 34% in the wild-type-in-
fected cells). About half of these cells were able to progress
to G1, while the rest remained in G2 (34 compared to 6% in
the WTA2-infected population). By 48 h postrelease, the
distribution of the adherent B2-infected population showed
approximately 60% of the population in G1/S, less than
10% in S and over 30% in G2/M. In this experiment, a large
portion of the population infected with B2 lifted into the
culture medium and was analyzed separately. The majority,
greater than 70%, of the cells in the supernatant had 2C
DNA content. A small percentage (10%) also had DNA
content less than 1C, indicative of some form of cell death.
These data suggest that while high levels of viral replication
may be required to arrest the cells in G2/M, continued viral
DNA synthesis is not necessary to maintain the block.
Characteristics of the B2-induced cell-cycle arrest in
semipermissive FR3T3 rat cells
Because viral DNA replication is markedly reduced in
nonpermissive cells, they provide a good system to separate
Fig. 4. Comparison of the accumulation of early and late viral proteins in
WTA2-, B2-, WTA2B2-, and wtB2-infected NIH3T3 cells. Infections of
NIH3T3 cells at an m.o.i. of 10 for each virus strain were carried out
according to protocol 1. Protein lysates were collected at various times and
one-fifth of the sample was assayed for early proteins and VP1 as described
under Materials and Methods. The times indicated are hours postrelease
from G0 (infections were carried out 4 h after G0 release).
Fig. 3. Cell-cycle analysis in infections with the wtB2 strain and in mixed
infections with WTA2  B2. Cells were synchronized and infected using
protocol 1, and the progression through the cell cycle was followed for
48 h. At various times, samples were fixed, stained, and analyzed by FACS.
The percentage of cells in G1( ), S (), and G2/M () at 48 h postrelease
is shown.
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the potential contribution of elevated viral proteins or out of
S viral replication to the cell-cycle arrest. For this reason,
infections were carried out with rat FR3T3 cells, which are
“semipermissive” (Chen and Fluck, 1993). In these exper-
iments, cells were synchronized using protocol 1, and an
m.o.i. of 50 PFU/cell was used. The experiment was carried
out up to 96 h since viral protein expression is not detectable
until the second cell cycle in FR3T3 rat cells (Chen and
Fluck, 1993). During the course of the experiments, two
distinguishable cell populations were observed: one that
rounded up and floated into the culture medium, and one
that remained adherent as a monolayer. These populations
were either combined (T, total population) or separated to
analyze the contribution of the monolayer (M) and the
supernatant (S) to the characteristics of the total population.
The kinetics of cell-cycle progression of the uninfected
FR3T3 cells (Table 6) was similar to that observed for
NIH3T3 cells. A first S peak was seen at 20 hpr; the end of
the first cell cycle occurred by 24 hpr, and a second S phase
was detected at 30 hpr. At 48 hpr, cell-cycle distributions
were indicative of an asynchronous population. From 60 to
96 hpr an increase in the percentage of cells in G1, and a
decrease in the percentage of cells in S phase, was observed,
reflecting a confluency-induced arrest in G0/G1. Infection
with WTA2 altered neither the progression through the first
two cell cycles nor the distribution of the cell population at
96 hpr. Analysis of the B2-infected cells showed a rise in
the G2/M population by 48 hpr, with an increasing fraction
of the arrested cells (up to 50% of the total population)
lifting into the medium. These supernatants contained a
high percentage of cells with 2C DNA content and with
apparent metaphase plates as observed by light microscopy.
In addition, the supernatant contained a population with less
than 1C DNA content, indicative of either cell death or
aberrant chromosome segregation. An example is shown in
Fig. 5.
The analysis of viral proteins and genomes in the differ-
ent subpopulations from B2-infected cells are shown in
Figs. 6A and 6B, respectively. Large T was detected in all
populations throughout the experiment. With increasing
time, elevated levels were observed in detached cells, com-
pared to the total population. Expression of VP1 became
detectable at 48 hpr. At this time, it was detected predom-
inantly in detached cells, and, by 96 hpr, cells that remained
in the monolayer had almost lost detectable VP1 expression.
Analysis of viral genomes (Fig. 6B) showed that the overall
amplification of viral genomes at 96 hpr was less than
10-fold. The genome level exhibited the same trend as large
T, with a slight elevation in the supernatant. Large T ex-
pression was markedly reduced and VP1 was undetectable
Table 4
Comparison of the ability of four hr-t mutants to induce a G2/M cell-cycle arrest in NIH3T3 cellsa
Virus Mockb B2b NG18b NG59b NG23b 18R4b 59RAb
Exp. 1 23 72 48 42 ND ND 46
Exp. 2 20 55 58 49 44 47 ND
a NIH3T3 cells were synchronized, released from G0 according to protocol 1, and infectedat an m.o.i. of 10 PFU/cell.
b At 48 h postrelease from G0, cell populations were fixed and analyzed by FACS for DNA content. The percentage of cells in the G2/M phase is shown.
Table 5
Cell-cycle analysis of mock-, WTA2-, and B2-infected NIH3T3 cells treated with aphidicolin or mimosinea
Time
(hpr)b
Untreated Aphidicolin at 24 hprc Mimosine at 24 hprc
G1d Sd G2d G1d Sd G2d G1d Sd G2d
Mock 24 53 9 38 53 9 38 53 9 38
30 58 38 5 77 5 18 86 8 6
36 36 35 28 84 4 12 90 5 5
48 61 20 12 84 7 9 81 11 8
WTA2 24 56 10 34 56 10 34 56 10 34
30 50 46 4 85 9 6 89 7 4
36 32 38 30 80 5 14 91 3 6
48 60 29 11 83 6 11 87 9 4
B2 24 33 8 58 33 8 58 33 8 58
30 32 45 24 60 6 34 61 8 31
36 14 33 53 49 13 38 63 7 30
48 18 35 47 59 9 33 60 6 35
48 Suppe 12 2 86 18 2 79 22 8 70
a Cells were synchronized and infected at an m.o.i. of 10 using protocol 2.
b Sample harvest time: hours postrelease from G0, equivalent to hours postinfection.
c Inhibitors 30 M aphidicolin or 400 M mimosine, added at 24 hpr.
d 5000 cells were analyzed for DNA content by FACS. Percentage of cells in G1, S, G2/M is given.
e FACS analysis of cells in the supernatant.
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in the parallel WTA2-infected population; however, viral
genome accumulation was similar to that seen in the B2-
infected population (data not shown). These results show
that FR3T3 are somewhat (semi) permissive for polyoma-
virus replication, as previously reported (Chen and Fluck,
1993), and hence, permit some temporary late gene expression.
Similar experiments carried out with the reconstructed
wtB2 strain also resulted in a G2/M cell-cycle arrest in a
fraction of the population (data not shown). In this case,
FR3T3 cells were followed for 4 weeks to assay for the
development of transformed foci. As shown in Table 7, a
delay in the onset of the development of transformed foci, a
decrease in the total number of foci developed, as well as a
reduction in their size, was observed in wtB2- compared to
WTA2-infected cells. Similar results were obtained in agar
assays (data not shown). In this case, abortive transforma-
tion was also severely reduced. To test the intrinsic trans-
formation potential of the wtB2 middle T protein, pUC-
WTA2 and pUC-wtB2 plasmids were constructed in which
the complete viral genomes were cloned at the EcoRI site in
the middle of the large T coding sequences, leaving an intact
middle T function but eliminating large T, and hence, rep-
lication and late gene expression. NIH3T3 cells were trans-
fected, analyzed for middle T expression, and assayed for
the development of foci. In both cases, the level of middle
T protein and number of transformed foci were proportional
to the concentration of transfected DNA. At equal middle T
levels, similar numbers of foci were obtained with both
plasmids (data not shown). To map the B2 mutation(s)
responsible for the inhibition of transformation, various
fragment exchanges were carried out in the wtB2 back-
ground. As discussed under Materials and Methods, wtB2
was produced by exchanging B2 sequences between BsrF1
and B1p1 (nt 400–1079) with the equivalent WTA2 frag-
ment. When the exchanged fragment was extended to
BsrF1-EcoR1 (nt 400–1562), the recombinant thus obtained
showed normal transformation properties tested in both
overgrowth of the monolayer as well as anchorage indepen-
dence. The abortive transformation potential was equally
restored. This mapping suggests that B2 sequences between
nt 1079 and 1562 are required to mediate the induction of
inhibition of transformation. A number of mutations in this
fragment are considered under Discussion.
Discussion
We have examined the effect of polyomavirus infection
on cell cycling. Infection of serum-stimulated NIH3T3 cells
with wild-type A2 and as well as A2-derived middle T 
small T defective mutants at a moderate multiplicity (10–20
PFU per cell) did not lead to a noticeable alteration of at
Table 6
Cell-cycle analysis of FR3T3 cells infected with WTA2 or B2a
Timeb Mockc WTA2c B2c
G1 S G2 G1 S G2 G1 S G2
0 89 5 6
12 86 7 7 84 9 4 87 8 6
20 24 49 27 38 35 27 25 40 35
24 67 17 16 65 22 13 67 14 19
30 45 45 10 34 26 11 35 58 7
36 54 31 16 56 26 18 24 47 29
48 Td 49 39 12 54 33 13 30 42 29
48 Md 41 38 21
48 Sd 30 32 38
60 Td 65 23 12 65 21 15 37 41 23
60 Md 45 36 19
60 Sd 20 25 55
72 Td 67 15 18 61 25 14 36 39 25
72 Md 42 36 22
72 Sd 27 28 46
84 Td 73 10 18 66 13 21 40 25 35
84 Md 55 27 17
84 Sd 19 17 64
96 Td 82 4 14 81 3 16 52 31 17
96 Md 67 21 12
96 Sd 30 21 49
a FR3T3 cells were synchronized and released from G0 according to protocol 1. Infections were carried out at 50 PFU/cell. Percentage of cells in G1, S,
or G2.M phases is shown.
b Sample harvest time: hours postrelease from G0.
c FACS analysis was carried out on 5000 cells for each sample, and the percentage of cells in G1, S, and G2/M was calculated as described under Materials
and Methods.
d In B2 infected cells, the cell population was either unfractionated (T  total) or separated into attached monolayer (M) and detached supernatant (S).
This does not apply to the mock- or WTA2-infected cells, which remained attached.
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least the first two cell cycles. In time, similarly to their
uninfected partners, infected cells underwent a contact in-
hibition of growth and became arrested in G0. In contrast,
parallel infection with middle T  small T defective hr-t
mutant B2 caused a cell-cycle arrest with G2/M DNA con-
tent in a large fraction of the population. This arrest was
strongly dependent upon the viral dose, becoming detect-
able at multiplicities of 5 PFU/cell. The proportion of cells
arrested with 2C DNA content reached 60–80% with a
multiplicity of infection of 30 or above. While this high
percentage was attained by the end of the second cell cycle
(or 48 hpr), a fraction of the cells were already arrested in
the first cycle. With increasing doses (e.g., m.o.i. of 50), a
modest arrest was also observed in WTA2 infection. As
described under Results, variable growth conditions af-
fected the extent of the arrest in infected NIH3T3 cell
populations. Semipermissive FR3T3 rat cells showed simi-
lar responses: unperturbed early cell cycling and conflu-
ency-induced G0 arrest following wild-type infection con-
trasting with G2/M arrest following B2 infection. Thus
these properties are not unique to the specific NIH3T3
subline used.
As reviewed briefly under Introduction, the B2 mutant
was isolated as part of a large group of transformation
defective mutants, named hr-t. The examination of other
hr-t mutants showed that the cell-cycle arrest is not unique
to the particular B2 mutant used for most of the studies.
Three other hr-t mutants tested generated an accumulation
of cells with 2C DNA content to a comparable extent and
with kinetics similar to those seen with B2. In contrast, no
arrest was observed in infections with the middle T  small
T defective mutant, A185, derived from WTA2. Likewise,
no arrest was observed in infections with a mutant recon-
structed in the A2 background with a deletion identical to
that of B2 (data not shown). Thus, the induction of a
cell-cycle arrest does not appear to be caused simply by the
absence of middle T and/or small T.
Fig. 5. FACS analysis of B2-infected FR3T3 rat cells at 48 h postrelease.
Infection of FR3T3 cells at an m.o.i. of 50 with B2 was carried out
according to protocol 1. Progression through the cell-cycle phases was
followed for 96 h. Cells were fixed and stained, and 5000 cells for each
sample were analyzed for DNA content by flow cytometry. FACS profiles
of samples taken at 48 hpr are shown. Cell populations were combined to
give a total population (A) or separated into the monolayer (B) or super-
natant (C). In C, the y-axis scale was adjusted (30 vs 70 for A and B) to
enhance visualization of the cell-cycle profile.
Fig. 6. Comparison of early and late viral proteins and viral genome levels
in subpopulations of B2-infected rat FR3T3 cells. Infection of FR3T3 cells
with B2 at an m.o.i. of 50 was carried out according to protocol 1. Cell
populations were harvested at the times shown. From 48 hpr, the popula-
tions were pooled to yield a total population (T) or separated into a
monolayer (M) or supernatant (S) fraction. Because 30–50% of the total
population was in the supernatant, the supernatant from two plates was also
combined and analyzed (S2). (A) Cell populations were processed for
protein analysis and assayed for large T, VP1, and actin as described under
Materials and Methods. (B) DNA was extracted from approximately 1 
105 cells, digested with EcoRI, and blotted in duplicate to nitrocellulose
membranes. Membranes were hybridized with a WTA2 genomic probe.
(*Samples with low ethidium bromide staining.)
Table 7
Development of transformed foci in WTA2- and wtB2-infected cellsa
m.o.i. WTA2b wtB2b
1 10 1 10
2 weeks 60 Large TMTC 0 0
3 weeks 6 Smallc 30 Smallc
4 weeks 16 Smallc 100 Smallc
a FR3T3 cells were synchronized and infected with WTA2 and wtB2 at
multiplicities of 1 and 10 PFU/cell according to protocol 1.
b WTA2-infected cells were fixed and stained and their foci counted at
2 weeks postinfection while independent plates of wtB2cells infected were
similarly processed at 2, 3, and 4 weeks post-infection.
c The foci developed wtB2 infected cells were considerably smaller in
size than those observed in WTA2-infected cells.
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The corollary conclusion, that the induction of a G2/M
cell-cycle arrest by the B2 mutant is not overcome by the
expression of middle T and/or small T, was also demon-
strated. The B2 deletion was repaired by exchange of a 679
base-pair WTA2 DNA fragment, restoring middle T 
small T expression in the B2 background. Infection with this
“wild-type B2” strain, which produces a high level of func-
tional middle T, also led to a G2/M cell-cycle arrest. Two
additional strains with reconstituted middle T and small T
functions from hr-t-derived genomes, 18R4 and 59RA, were
also found to induce a G2/M cell-cycle arrest. This conclu-
sion was also supported by the results of infection of
NIH3T3 cells stably expressing middle T and/or small T. In
the case of small T expressing cells, results were unequiv-
ocal: the fraction of cells arrested with 2C DNA content was
comparable to that observed in infections of the parental
NIH3T3 cells. A decrease in the fraction of arrested cells
was observed in middle T- and middle T  small T-ex-
pressing cells. However, this is likely to result from the
reduction in infection efficiency seen with transformed
cells. Overall the results suggest that middle T and small T
do not have the capacity to overcome the cell-cycle arrest
induced by B2 and other hr-t mutants.
Infection of FR3T3 cells with wtB2 also permitted us to
test the effect of a cell-cycle arrest on neoplastic transfor-
mation. Despite the production of a transforming middle T
protein, a long delay and large decrease in transformation
were observed in wtB2- compared to WTA2-infections. An
investigation of the surviving transformants is underway.
The cell cycle arrest-mediated inhibition of transformation
by hr-t-related mutants clearly identifies a unique property
of hr-t mutants. Preliminary results suggest that this effect is
related to the “dominant lethal” inhibition of transformation
phenotype previously described in mixed infection of hr-t
and transformation-competent strains (Fluck et al., 1977).
The stage of the cell-cycle arrest in B2-infected cells was
deemed to be the G2/M phase, based primarily on DNA
content (2C). Therefore, the potential contribution of the
amplification of viral genomes to the total cellular DNA
content needed to be taken into account. However, WTA2-
infected cells that contained similar levels of viral genomes
as B2-infected cells were found to arrest with 1C DNA
content between the second and third cell cycle. Addition-
ally, accumulation of cells with 2C DNA content was also
seen in infection of FR3T3 semipermissive cells, with 100-
fold overall reduction in genome amplification. Therefore, it
is unlikely that the level of viral genomes was high enough
to lead to the misidentification of the stage of the cell-cycle
block in B2-infected cells. The morphological appearance
of the arrested cells also supported the identification of
G2/M as the stage of the arrest: some arrested cells rounded
up, displayed visible metaphase plates, and easily detached
from the monolayer. The appearance of metaphase plates in
arrested cells may reflect a block in the completion of
mitosis, for example, in the disassembly of the microtu-
bules. However, metaphase plates were not seen in all G2/M
arrested cells, perhaps reflecting arrest at an earlier stage
(e.g., late G2). Interestingly, wild-type SV40 induces a G2
cell-cycle arrest in lytic infection of most cell types
(Scarano et al., 1994; Lehman et al., 2000). In this case, the
activation of M-phase promoting factor is inhibited, sug-
gesting a defect in the initiation of mitosis. With time, the
arrested cells undergo a second S phase without an inter-
vening mitosis, resulting in the accumulation of polyploid
cells (Lehman et al., 2000).
Various hypotheses for the cell-cycle arrest were consid-
ered. Since genome replication is not restricted to the S
phase (L. Chen, unpublished data), the accumulation of
G2/M cells could reflect the activity of the completion of
S-phase checkpoint control, preventing mitosis (Stewart and
Enoch, 1996). This hypothesis was ruled out by the use of
DNA synthesis inhibitors, aphidicolin and mimosine. Ad-
dition of these inhibitors in G2 did not prevent the exit of
G2/M among WTA2-infected cells. In contrast, in B2-in-
fected cells, treatment with either inhibitor did not relieve
the cell-cycle arrest, suggesting that continued viral DNA
synthesis is not required to maintain cells in the arrested
state. However, mechanisms based upon the presence of
replication intermediates and/or single-stranded DNA are
not ruled out by these experiments. Furthermore, results
with FR3T3 also support the hypothesis that the induction
of the cell-cycle arrest does not require a high level of viral
replication.
B2 sequences responsible for the induction of the cell-
cycle arrest were mapped by fragment exchanges between
WTA2 and wtB2 to a fragment encompassing nucleotides
1079–1562. Sequence comparison shows six single nucle-
otide mutations at residues 1182, 1342, 1349 1351, 1403,
and 1428. Taking the most likely hypothesis that the muta-
tion(s) exert their effect through the affected proteins, they
could target large T and/or middle T (in wtB2). Since the
cell-cycle arrest is observed with the B2 mutant which does
not synthesize middle T and since the wtB2 middle T
protein has a normal transforming phenotype, we hypothe-
size that these mutations exert their effect in the large T
frame, in which they affect four residues, and a conservative
ser290thr change. All these mutations are located in the
C-terminal domain of large T, upstream of the site-specific
DNA-binding activity. One of these mutations, lys281Asn,
is located in a sequence conserved in polyoma and SV40
large T, encompassing a nuclear localization sequence, and
immediately downstream from a putative Pin-1 sensitive
site. Further experiments will determine which among these
four changes (and whether additional ones outside of the
1079–1562 fragment) are required for the cell-cycle phe-
notype arrest, and other properties of the B2 mutant.
As recently described, these additional properties of hr-t
mutants include a marked overexpression of early and late
genes (mRNA and proteins) compared to WTA2-derived
middle T  small T mutants and a higher degree of viral
amplification (Chen and Fluck, 2001b and unpublished ob-
servations). These differences are documented here for the
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B2 mutant. In particular, the expression of the VP1 late
protein was quantitated to be in 30-fold excess relative to
WTA2 in NIH3T3 infections. Furthermore, mixed infection
with WTA2 demonstrates a preferential expression, and
replication, of the B2 genome over that of WTA2. The
mechanism underlying the gene overexpression, high de-
gree of viral amplification, and preferential expression/rep-
lication in mixed infections is presently unknown and under
further study. Preliminary results suggest that this overex-
pression phenotype maps to the same fragment as the cell-
cycle arrest phenotype. Given the effect of this mutation(s)
on the expression of viral proteins in the absence of middle
T  small T cell, it is likely to have been coselected in the
original mutant search as a compensation for the absence of
middle T  small T.
The cell-cycle block may be caused directly by large T
mutation(s) or overexpression of one or more viral gene
products or a combination. A number of observations sug-
gest that high overexpression of the VP1 capsid protein in
B2 infections may play a role. The separation of arrested
cells detached from the monolayer among infected FR3T3
cells showed a correlation between cell-cycle arrest and
expression of VP1, since VP1-expressing cells were highly
enriched in the supernatant. VP1 expression is eliminated
from transformed cells and from most tumors cells. Prelim-
inary experiments showed an interaction between WTA2-
and B2-VP1 and -tubulin in coimmunoprecipitation of
late-stage infection in NIH3T3 cells. These interactions
have also been seen by immunostaining of tumor tissues,
which detected VP1 protein in association with the spindle
apparatus in mitotic cells (Talmage et al., 1992). The bind-
ing of VP1 to - (and perhaps )-tubulin may play an
inhibitory role in their mitotic function. A recent report
demonstrated that expression of VP1 in yeast cells results in
a mitotic arrest (Palkova et al., 2000). Preliminary experi-
ments with expression vectors showed that the expression of
the capsid protein alone (both WTA2- or B2-VP1) is toxic
in FR3T3 and NIH3T3 cells. However, in this case cells
detached with1C DNA content, consistent with either cell
death or with unequal chromosome segregation. Further




The B2 mutant contains a 241 base-pair deletion (nucle-
otides (nt) 491–731) in the large T intron resulting in the
absence of middle T and small T expression (Hattori et al.,
1979). This mutation results in the synthesis of large T, but
no other early proteins. If the splicing of the middle T intron
were to take place, the resulting protein would be 80 amino
acids smaller than small T. Utilization of the small T splice
sites would result in a protein 26 amino acids larger than
large T. The absence of these proteins suggests that the
splicing of middle T and small T transcripts is impeded by
the deletion, as is the case for A185 (Chen and Fluck,
2001b). For these studies, an unrelated 11 base-pair deletion
from nucleotides 46 to 57 was repaired. Wild-type A2
(WTA2) (Soeda et al., 1980) was chosen as a wild-type
reference. WTA2-derived middle T  small T defective
A185 mutant (Lania et al., 1979) with a 71 base-pair dele-
tion (nucleotides 646–717) in the large T intron was used
for comparison. A wild-type B2 (wtB2) was constructed by
replacement of sequences between 400 (BsrFI) and 1079
(BlpI) encompassing the B2 deletion with the corresponding
WTA2 DNA fragment, thus restoring middle T  small T
expression. The other hr-t mutants NG23, NG18, NG59,
and the rescued wild-types 18R4 and 59RA, have been
described (Benjamin, 1970; Feunteun et al., 1976). Virus
stocks were prepared in NIH3T3 cells and checked for the
absence of defectives. Titers were calculated using standard
plaque assays and confirmed by comparison of the levels of
input genomes in infections at multiplicities based upon the
plaque assay derived titers.
Cells and infections
The mouse NIH3T3 cell subline used in this study was
originally obtained from T. Benjamin. This line has a func-
tional p53 function, as it induces the expression of p21 in
response to treatment with actinomycin D, however, it is
negative for p16 expression. NIH3T3 and FR3T3 (Fischer
rat) (Seif and Cuzin, 1977) cells were cultured at 37°C in
5% CO2 with Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) supplemented with 10% heat-inactivated
bovine calf serum (Gibco or Sigma). For induction of qui-
escence and release from G0, two protocols were used. In
Protocol 1, cells were grown to 90% confluence, subjected
to starvation in 0.5% serum medium for 24 h, and released
from G0 by replating at a lower density in 10% serum
medium. Infection was carried out after reattachment (4 h),
allowing 1 h for adsorption. In Protocol 2, cells were seeded
at subconfluent levels in 10% serum medium, grown for 1
day, incubated in 0.5% serum medium for 24 h, infected,
and released from G0. Unless otherwise indicated, all in-
fections were carried out at an m.o.i. of 10 PFU per cell, and
the infection lysate was removed prior to the addition of
10% serum medium.
FACS analysis
At the time of sampling, cells were treated with trypsin,
resuspended in 1 ml of phosphate-buffered saline (1PBS)
supplemented with 2% serum, and fixed in 10 ml 80%
ethanol for 30 min on ice. Samples were stored at 4°C until
analysis. Cells were then washed once with 1 PBS and
stained for 30 min at room temperature with propidium
iodide solution: 0.1 mg/ml RNase A, 0.1% Triton- -100,
0.5 mM EDTA, and 0.05 mg/ml propidium iodide in 1
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PBS. A total of 5000 cells were then assayed for DNA
content by a Becton–Dickinson FACS Vantage cell sorter
using CellQuest. Percentages of G1, S, and G2/M were
calculated using Multiplus or WinCycle for Windows.
Analysis of viral DNA
Infected cells were lysed in 10 mM Tris (pH 7.6), 10 mM
EDTA, 0.2% sodium dodecyl sulfate (SDS) and treated
overnight at 37°C with 50 g/ml proteinase K (Sigma).
Total DNA was extracted with phenol–chloroform and
treated with RNaseA by standard procedures. Samples were
digested with the restriction endonuclease EcoRI (Gibco-
BRL) to linearize polyomavirus DNA, electrophoresed in
1% agarose, stained with ethidium bromide to check the
loading, and blotted to Hybond membranes (Amersham).
Hybridization was carried out at 65°C in 1 Denhardt’s
solution, 5 SSPE, and 0.5% SDS with a 32P-labeled
WTA2 genome probe. Hybridization probes were labeled to
a specific activity of 1–2  109 cpm/g with [32P]dCTP
(3000 Ci/mmol; New England Nuclear) using a multi-
prime DNA-labeling kit (Amersham). Hybridized blots
were washed using stringent conditions and exposed to
X-ray film (Amersham). To quantitate the level of viral
genomes, membranes were scanned with a phosphorImager
(Molecular Dynamics).
Analysis of viral proteins
Infected cells were lysed in sample buffer (5% SDS,
0.03% bromphenol blue, 20% glycerol, 5% -mercapto-
ethanol) and boiled for 5 min. Aliquots were electropho-
resed in 5% stacking/10% resolving polyacrylamide SDS
gels (Bio-Rad) and electroblotted to PVDF membranes
(NEN). A polyclonal rat antitumor serum was used as the
source of primary antibody to detect polyomavirus early
proteins. The primary antibody for the detection of VP1
(rabbit anti-VP1) was a gift from Dr. Robert Garcea. The
primary antibody for detection of actin (goat antiactin) was
purchased from Santa Cruz Biotechnology. Goat anti-rat
IgG, goat anti-rabbit IgG, and sheep anti-goat IgG, all cou-
pled to horseradish peroxidase (Pierce), were used as sec-
ondary antibodies. For detection, a chemiluminescent assay
was performed using SuperSignal solutions (Pierce) and
membranes were exposed to X-ray film (Amersham).
Plasmids
Plasmids pUC-WTA2 and pUC-wtB2 were constructed
by cloning these two viral genomes at the EcoRI site (nt
1562), that is, downstream of the middle T termination
codon (nt 1499). This strategy interrupts the large T coding
region, which results in the absence of plasmid replication
and thus absence of late gene expression.
Neoplastic transformation assays
FR3T3 cells were synchronized and infected using pro-
tocol 1 described above with the following exception. After
infection, cells were refed with 5% serum medium and the
medium was replaced as needed. The development of foci
of cells overgrowing the monolayer was monitored, and, at
the indicated times, the monolayers were fixed and stained
with 1% methylene blue in 5% acetic acid and 20% isopro-
panol, and foci were counted. For anchorage independence
assays, cells were transferred into agar-containing medium
at 24 h postinfection. Cells (1  105 or 2  104) were
resuspended in medium supplemented with 20% serum con-
taining 0.36% agar and overlayed onto a solid agar (0.54%)
layer containing medium supplemented with 5% serum.
To assay for the transforming capacity of WTA2- and
wtB2-encoded middle T proteins, plasmids pUC-WTA2
and pUC-wtB2 were transfected into NIH3T3 cells using
lipofectamine (Gibco) according to manufacturer’s instruc-
tions. The development of foci was monitored as described
above.
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